The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.

Lorenc, Z Paul; Adelglass, Jeffrey M; Avelar, Rui L; Baumann, Leslie; Beer, Kenneth R; Cohen, Joel L; Cox, Sue Ellen; Dayan, Steven H; Dover, Jeffrey S; Downie, Jeanine B; Draelos, Zoe Diana; Goldman, Mitchel P; Gross, John E; Joseph, John H; Kaufman-Janette, Joely; Moy, Ronald L; Nestor, Mark; Schlessinger, Joel; Smith, Stacy R; Weiss, Robert A

Lorenc, Z Paul; Adelglass, Jeffrey M; Avelar, Rui L; Baumann, Leslie; Beer, Kenneth R; Cohen, Joel L; Cox, Sue Ellen; Dayan, Steven H; Dover, Jeffrey S; Downie, Jeanine B; Draelos, Zoe Diana; Goldman, Mitchel P; Gross, John E; Joseph, John H; Kaufman-Janette, Joely; Moy, Ronald L; Nestor, Mark; Schlessinger, Joel; Smith, Stacy R; Weiss, Robert A.

Aesthet Surg J ; 41(12): 1423-1438, 2021 11 12.

Article in En | MEDLINE | ID: mdl-33944913

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blepharoptosis / Skin Aging / Botulinum Toxins, Type A / Neuromuscular Agents Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: Aesthet Surg J Year: 2021 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google